Testing effectiveness (Phase 2)Active Not RecruitingNCT04374305
What this trial is testing
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+2 more
Scott R. Plotkin, MD, PhD 100